David Funda, M.D., Ph.D., is a Senior Research Scientist at the Institute of Microbiology, Czech Academy of Sciences, Prague. He received his Ph.D. (2000) from the First Faculty of Medicine, Charles University, Prague. He conducted a substantial part of his research at the Bartholin Institute, Copenhagen, Denmark, and completed a JDRF-funded postdoctoral fellowship at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, in the diabetes research group led by Prof. L. C. Harrison.
His research focuses on mucosal immunology, autoimmunity, and the effects of dietary and environmental factors on immune-mediated diseases, particularly type 1 diabetes. His pioneering study demonstrated that a gluten-free diet prevents diabetes in NOD mice (1999). His subsequent research has addressed immune mechanisms of dietary interventions, intestinal inflammation, and the development of tolerogenic dendritic cells as a potential cellular therapy for autoimmune diseases such as type 1 diabetes.
He is a member of several international scientific societies, including the Society for Mucosal Immunology (SMI), the European Association for the Study of Diabetes (EASD), and was a founding member of the Federation of Clinical Immunological Societies (FOCIS).
David Funda, M.D., Ph.D., is a Senior Research Scientist at the Institute of Microbiology, Czech Academy of Sciences, Prague. He received his Ph.D. (2000) from the First Faculty of Medicine, Charles University, Prague. He conducted a substantial part of his research at the Bartholin Institute, Copenhagen, Denmark, and completed a JDRF-funded postdoctoral fellowship at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, in the diabetes research group led by Prof. L. C. Harrison.
His research focuses on mucosal immunology, autoimmunity, and the effects of dietary and environmental factors on immune-mediated diseases, particularly type 1 diabetes. His pioneering study demonstrated that a gluten-free diet prevents diabetes in NOD mice (1999). His subsequent research has addressed immune mechanisms of dietary interventions, intestinal inflammation, and the development of tolerogenic dendritic cells as a potential cellular therapy for autoimmune diseases such as type 1 diabetes.
He is a member of several international scientific societies, including the Society for Mucosal Immunology (SMI), the European Association for the Study of Diabetes (EASD), and was a founding member of the Federation of Clinical Immunological Societies (FOCIS).